key: cord-0684393-ls4xk2bh authors: Watford, Daniel J.; Cheng, Xingxing S.; Han, Jialin; Stedman, Margaret R.; Chertow, Glenn M.; Tan, Jane C. title: Toward telemedicine‐compatible physical functioning assessments in kidney transplant candidates date: 2020-12-14 journal: Clin Transplant DOI: 10.1111/ctr.14173 sha: 17b08671a01ac21a3d01a2700047b28b9da359db doc_id: 684393 cord_uid: ls4xk2bh Frailty is associated with adverse kidney transplant outcomes and can be assessed by subjective and objective metrics. There is increasing recognition of the value of metrics obtainable remotely. We compared the self‐reported SF‐36 physical functioning subscale score (SF‐36 PF) with in‐person physical performance tests (6‐min walk and sit‐to‐stand) in a prospective cohort of kidney transplant candidates. We assessed each metric's ability to predict time to the composite outcome of waitlist removal or death, censoring at transplant. We built time‐dependent receiver operating characteristic curves and calculated the area under the curve [AUC(t)] at 1 year, using bootstrapping for internal validation. In 199 patients followed for a median of 346 days, 41 reached the composite endpoint. Lower SF‐36 PF scores were associated with higher risk of waitlist removal/death, with every 10‐point decrease corresponding to a 16% increase in risk. All models showed an AUC(t) of 0.83–0.84 that did not contract substantially after internal validation. Among kidney transplant candidates, SF‐36 PF, obtainable remotely, can help to stratify the risk of waitlist removal or death, and may be used as a screening tool for poor physical functioning in ongoing candidate evaluation, particularly where travel, increasing patient volume, or other restrictions challenge in‐person assessment. Frailty is a pathobiological process characterized by loss of physiologic reserve and increased vulnerability to stressors. 1 Originally described as an adverse consequence of aging, frailty overlaps with but is separate from comorbidity and disability. In clinical practice, frailty is often difficult to define or measure, and there is little consensus regarding specific elements to be included in operational definitions. Thus, we frequently utilize surrogate measures, especially physical functioning defined by the ability to perform specific physical tasks. Due to the high prevalence of comorbidities, including diabetes mellitus and cardiovascular disease, as well as pathophysiologic pathways of uremia including inflammation and protein energy wasting, frailty is prevalent among kidney transplant candidates and associated with unfavorable waitlist and posttransplant outcomes. [2] [3] [4] Despite these well-documented associations, recent data indicate that 75% of United States kidney transplant programs do not assess frailty as part of routine pretransplant evaluation, 5 representing lost opportunities for therapeutic engagement. Part of the challenge of operationalizing pretransplant frailty assessments pertains to confusion surrounding the myriad surrogate measures 2 and how to act on them. Thus, we previously detailed the utility of physical performance measures, namely the 6-min walk test (6MWT) and the sit-to-stand test (STS), in kidney transplant candidates near the top of the waitlist. 6 These tests objectively and reproducibly assess patients' ability to perform standardized physical tasks and are routine tests in physical medicine and rehabilitation. 7, 8 As valuable as these in-person assessments of physical performance may be, there is also a role for metrics that capture elements of frailty without obligating in-person evaluation. For example, self-reported physical health and function may be evaluated remotely using well-validated questionnaires. 9 This approach can be particularly advantageous when considering the distances and burdens endured by patients when traveling to transplant centers for evaluation or, as waitlist management becomes increasingly complicated (and prolonged), re-evaluations. September 2015 and March 2019 travelled a median distance of 31 miles for their transplant evaluation appointments, with 16% traveling 100 miles or more. The median travel time was 87 min with 36% traveling for 2 or more hours. Our instance is not unique: the distance to transplant programs has been reported to be 23 to 46 miles, with marked variation by region. 10 At each visit, the nurse coordinators performed the 6MWT and STS. The SF-36 PF questionnaire was obtained over the phone prior to the scheduled visit by a patient care coordinator or obtained during the visit. The 10-item SF-36 PF questionnaire is the physical functioning subset of the Medical Outcomes Study Short Form 36-item questionnaire. 16, 22 It asks survey respondents to answer questions regarding their ability to perform physical tasks, for example, walking multiple blocks, with the responses of "not limited," "limited a little," or "limited a lot". These responses are scored as 10, 5, and 0 respectively. The scores for each question were aggregated to give a total score from 0 to 100: the higher the score, the better the self-reported physical functioning. An in-person language interpreter was available to accommodate patients whose preferred language was not English. The research and the clinical transplant teams (including physicians, nurses, dietitians, and social workers) were blinded to the results of the SF-36 PF throughout the duration of the study. From the time of first SF-36 PF and physical performance assessment, we ascertained waitlist outcomes including transplant (at Stanford or another program), removal from our waitlist, and death. To reduce reporting bias (ie, adverse events are more likely to be reported outside the follow-up schedule), we censored data at the time of last scheduled follow-up. The primary study outcome was a composite of death or waitlist removal. We have shown previously 6 that 6MWT and STS were strongly associated with this composite outcome and death and provided information beyond commonly collected clinical characteristics. We therefore chose to compare SF-36 PF scores to 6MWT and STS scores by building a series of nested survival models that included clinical characteristics alone as well as clinical characteristics plus each physical functioning metric (6MWT, STS, and SF-36 PF). We compared model fit by determining the Akaike information criterion (AIC) for each model, with lower values indicating better model fit. We compared baseline characteristics, stratified by SF-36 PF score < 75 or ≥75. We utilized a threshold score of 75 on the SF-36 PF, as a score < 75 has previously been demonstrated to be independently associated with higher mortality in incident patients with end-stage kidney disease (ESKD). 23 Categorical variables were compared by chi-square tests and continuous variables by Kolmogorov-Smirnov, a non-parametric test. We expressed categorical variables as frequencies (percentages) and continuous variables as medians (25 th -75th percentile range), given skewed distributions. We estimated correlation between SF-36 PF, STS, and 6MWT by linear regression, except in the case of STS where correlation was estimated by the zero inflated Poisson model because of the high occurrence of a zero score for the STS test. 24 We assessed the ability of each metric to predict our primary out- at 1 year quantifies the ability of the measure to predict the primary outcome within 1 year. We included multivariable adjustment for demographic factors and comorbidities including dialysis vintage, diabetes status, presence of atherosclerotic disease, and assistive walking device. Twenty-one percent of patients (n = 42) used an assistive device, which may have differentially affected their abilities to perform daily tasks as well as the 6MWT and STS. We therefore performed a sensitivity analysis excluding these patients. We do not have an external validation cohort. We performed internal validation using bootstrapping to compute a measure of optimism. 27 Briefly, the bootstrap method used sampling with replacement to generate 1000 separate bootstrap datasets with N = 199. The pre- Tourism." Because the study used data being collected for routine clinical purposes and was defined as "minimal risk," the Institutional Review Board waived the need to obtain individual-level consent. Our cohort consisted of 199 patients, 70 with SF-36 PF < 75 and 129 with SF-36 PF ≥ 75 (Table 1) . Patients with lower SF-36 PF scores were older, more likely to be female, had longer dialysis vintage, more likely to have diabetes mellitus, coronary artery disease, and peripheral artery disease, and more likely to use assistive devices for ambulation. The median physical performance testing results Previously, we demonstrated that the physical performance metrics of 6MWT and STS were closely associated with waitlist outcomes in kidney transplant candidates at the top of the waitlist and provide information relevant to risk stratification beyond that of commonly collected clinical variables. 6 In this study, we demonstrate that SF-36 PF subscale, a questionnaire that relies on patient self-report, gave scores that were directly correlated with 6MWT and STS results and exhibited similarly very good discriminatory capacity for distinguishing patients who will die or be removed from the waitlist from those who will not at 1 year. While in-person evaluation is certainly an invaluable component of the pretransplant assessment, we submit that the SF-36 PF could be highly informative as an adjunct to physical performance testing and, given its compatibility with remote and telehealth technologies, may be deployed as an initial screening tool for remotely monitoring patients with barriers to in-person evaluation. The SF-36 PF, 6MWT, and STS measure different domains of physical functioning, which in turn is subsumed under and frequently conflated with frailty ( Figure 3 ). We submit that the SF-36 PF assesses the patient's global physical functioning, or ability to perform physical tasks on a day-to-day basis, whereas the STS and 6MWT measure more specific aspects contributing to this global functioning, that is, lower extremity strength, balance, and cardiorespiratory fitness. Our result therefore shows that, unsurprisingly, sire for more patients with advanced chronic kidney disease to be treated with preemptive transplantation rather than dialysis will likely cause sizeable increases in referral to transplant programs. 35, 36 The recent global pandemic has also set forth an expansion of telemedicine services. 37 to refine the optimal strategy and timing of its application. Research reported here was supported by the American Heart The data that support the findings of this study are available from the corresponding author upon reasonable request. Additional supporting information may be found online in the Supporting Information section. Internal validation was performed to correct the AUC(t) for overfitting of the survival models in Table 2 . Report from the American Society of Transplantation on frailty in solid organ transplantation Implications of frailty for peritransplant outcomes in kidney transplant recipients Frailty and early hospital readmission after kidney transplantation Frailty and access to kidney transplantation Perceptions and practices regarding frailty in kidney transplantation: results of a national survey Physical performance testing in kidney transplant candidates at the top of the waitlist Timed mobility: description of measurement, performance, and dimensionality among older adults The predictive validity of physical performance measures in determining markers of preclinical disability in community-dwelling middle-aged and older adults: a systematic review Comparison of selfreport-based and physical performance-based frailty definitions among patients receiving maintenance hemodialysis The geography of kidney transplantation in the United States Distance to kidney transplant center and access to early steps in the kidney transplantation process in the Southeastern United States Barriers facing patients referred for kidney transplant cause loss to follow-up Patient-reported barriers to the prekidney transplant evaluation in an at-risk population in the United States The interplay of socioeconomic status, distance to center, and interdonor service area travel on kidney transplant access and outcomes Distance from a transplant center and getting listed for a transplant Adult measures of general health and health-related quality of life: Medical Outcomes Study Short Form 36-Item (SF-36) and Short Form 12-Item (SF-12) Health Surveys, Nottingham Health Profile (NHP) Functional status and survival after kidney transplantation Functional status, time to transplantation, and survival benefit of kidney transplantation among wait-listed candidates Development of the kidney disease quality of life (KDQOL) instrument Health-related quality of life as a predictor of mortality and hospitalization: the Dialysis Outcomes and Practice Patterns Study (DOPPS) A new approach to kidney wait-list management in the kidney allocation system era: pilot implementation and evaluation SF-36 Physical and Mental Health Summary Scales. A User's Manual Significance of frailty among dialysis patients A coefficient of determination for generalized linear models Survival model predictive accuracy and ROC curves Time-dependent ROC curve analysis in medical research: current methods and applications Regression Modeling Strategies: With Applications to Linear Models, Logistic and Ordinal Regression and Survival Analysis Assessing the performance of prediction models: a framework for traditional and novel measures Pre-kidney transplant lower extremity impairment and post-kidney transplant mortality The six minute walk test accurately estimates mean peak oxygen uptake Importance of assessing cardiorespiratory fitness in clinical practice: a case for fitness as a clinical vital sign: a scientific statement from the american heart association Six-minute walk test predicts allcause mortality and technique failure in ambulatory peritoneal dialysis patients Exercise capacity as a predictor of survival among ambulatory patients with end-stage renal disease A vision for advancing american kidney health: view from the US Department of Health and Human Services Implications of the Advancing American Kidney Health Initiative for kidney transplant centers The Advancing American Kidney Health (AAKH) executive order: promise and caveats for expanding access to kidney transplantation COVID-19 transforms health care through telemedicine: evidence from the field A cost comparison for telehealth utilization in the kidney transplant waitlist evaluation process Implementation of telehealth is associated with improved timeliness to kidney transplant waitlist evaluation